Pricing

TRI LOCUM PARTNERS LP

0 followers ·
NEW YORK NY Investment Advisor Hedge Fund
13F Summary

Subscription Required

Equal-WT
WhaleScore 2.0 ?

85

S&P 500
WhaleScore ?

Subscription Required

Equal-WT
WhaleScore 1.0 ?

TRI Locum Partners is based out of New York. TRI Locum Partners is a hedge fund with 5 clients and discretionary assets under management (AUM) of $357,536,952 (Form ADV from 2024-03-28). Their last reported 13F filing for Q1 2024 included $288,365,187 in managed 13F securities and a top 10 holdings concentration of 62.41%. TRI Locum Partners's largest holding is Teva Pharmaceutical Industries Ltd, ADR with shares held of 2,216,188. Whalewisdom has at least 14 13F filings, and 2 13G filings

2024-03-31

Top Buys (13F)

Name % Change
SILK Silk Road Medical In 6.88%
MRK Merck & Co 5.45%
VRTX Vertex Pharmaceutica 5.16%
BAX Baxter International 4.71%
MRUS Merus BV 4.47%

2024-03-31

Top Sells (13F)

Name % Change
ABBV AbbVie Inc 11.89%
KVUE Kenvue Inc (PUT) 6.88%
GEHC GE HealthCare Techno 6.07%
BIIB Biogen Inc 5.42%
CTLT Catalent Inc 5.38%

2024-03-31

13F Holdings Summary

Name $ Change
TEVA Teva Pharmaceutical 10.84%
AVDL Avadel Pharmaceutica 6.97%
SILK Silk Road Medical In 6.88%
NTRA Natera Inc 6.03%
ASND Ascendis Pharma A/S 5.91%

2024-03-31

13F Activity

Market Value $288m, Prior: $219m
Inflows (Outflows) as % of Total MV +2.8492%
New Purchases 13 stocks
Added To 8 stocks
Sold out of 10 stocks
Reduced holdings in 6 stocks
Top 10 Holdings % 62.41%
Turnover %[1] 62.16%
Turnover Alt %[2] 38.67%
Time Held Top 20 1.5 quarters
Time Held Top 10 0.7 quarters
Time Held All 3.07 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

2024-03-31

13F Sector Allocation Over Time

2024-03-31

Analysis

Top 20 equal-weighted holdings. Performance numbers calculated through 2024-03-31

Portfolio Performance